Loading the section…
The price of Qiagen N.V. (QGEN) on October 9, 2026 is 45.38 USD, +1.91% on the day. Over 52 weeks the stock traded between 32.53 USD and 57.82 USD; the price now sits 51% of the way up that range. Over the past year the price changed by -4.98%.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −3.90 %
Qiagen N.V. trades on NYSE under the ticker QGEN. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks QGEN has traded between 32.53 $ and 57.82 $. As of 9 October 2026 the price stood 50.81 % of the way from the 52-week low to the high.
Over one year QGEN shares fell 4.98 %; over six months they rose 10.98 %. Volatility over 90 days is 35.86 %. Dividends are not included: this is price change only, as of 9 October 2026.
Qiagen N.V. reported revenue of 2.1B $ and net income of 425M $ for the latest fiscal year. Net margin is 20.33 %. Revenue changed by +5.65 % year over year. Earnings per share are 1.94 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 44.99 | 45.61 | 44.79 | 45.38 | 1M |
| 8 October 2026 | 44.44 | 44.80 | 43.65 | 44.53 | 2M |
| 7 October 2026 | 45.61 | 46.09 | 44.78 | 44.79 | 3M |
| 6 October 2026 | 47.25 | 47.28 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Qiagen N.V. (QGEN) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, revenue was 2.1bn $, net income was 424.9m $. Incorporated in NL.
This summary is compiled automatically from SEC filings and exchange data.
Address:HULSTERWEG 82, PL VENLO, 5912 PL
QGEN has a return on equity of 11.25 %, above the sector median of −41.68 %. Return on assets is 6.76 %, above the sector median of −32.11 %. Operating margin is 22.29 %, above the sector median of −26.84 %.
| 428M |
| RVMDRevolution Medicines, Inc. | 189.76 | +0.87 % | 409M |
| HALOHalozyme Therapeutics, Inc. | 110.42 | +0.53 % | 253M |
| BIIBBiogen Inc. | 225.71 | +3.33 % | 227M |
| KODKodiak Sciences Inc | 99.87 | +5.95 % | 219M |
| 45.27 |
| 45.65 |
| 3M |
| 5 October 2026 | 44.78 | 46.01 | 44.46 | 45.79 | 3M |
| 2 October 2026 | 42.45 | 45.60 | 42.18 | 44.75 | 5M |
| 1 October 2026 | 43.85 | 43.87 | 41.94 | 42.04 | 3M |
| 30 September 2026 | 44.40 | 44.70 | 43.76 | 43.76 | 2M |
| 29 September 2026 | 44.08 | 44.66 | 44.04 | 44.40 | 4M |
| 28 September 2026 | 44.65 | 45.53 | 44.37 | 45.01 | 3M |
| 25 September 2026 | 44.73 | 44.80 | 44.00 | 44.18 | 1M |
| 24 September 2026 | 44.08 | 45.21 | 44.00 | 44.56 | 2M |
| 23 September 2026 | 43.49 | 43.92 | 42.56 | 43.71 | 3M |
| 22 September 2026 | 44.43 | 44.47 | 43.62 | 43.69 | 1M |
| 21 September 2026 | 44.48 | 44.82 | 43.99 | 44.78 | 2M |
| 18 September 2026 | 44.30 | 44.36 | 43.31 | 43.33 | 2M |
| 17 September 2026 | 43.79 | 44.57 | 43.65 | 44.38 | 2M |
| 16 September 2026 | 42.58 | 43.46 | 42.56 | 42.90 | 1M |
| 15 September 2026 | 42.03 | 43.09 | 42.02 | 42.48 | 2M |
| 14 September 2026 | 42.92 | 42.94 | 41.74 | 41.88 | 2M |